The domestic sales rights for 8 types of MSD vaccines have changed hands recently. Although HK Inno.N was in charge of joint sales for MSD vaccines in Korea, the vaccines will be separately sold by Boryung Biopharma and Kwangdong Pharmaceutical each.

After signing a copromotion agreement with MSD for its vaccines at the end of 2021, HK Inno.N began joint sales last year. However, with this transfer of sales rights, the company is effectively withdrawing from the vaccine business after 2 years.

According to industry sources on the 23rd, MSD’s partner in joint sales and distribution of its 8 vaccines will be changed from HK Inno.N to Boryung Biopharma and Kwangdong Pharmaceutical